A

Active Biotech AB publ
STO:ACTI

Watchlist Manager
Active Biotech AB publ
STO:ACTI
Watchlist
Price: 0.0435 SEK -1.14% Market Closed
Market Cap: 114.7m SEK

Wall Street
Price Targets

ACTI Price Targets Summary
Active Biotech AB publ

Wall Street analysts forecast ACTI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACTI is 0.2631 SEK with a low forecast of 0.2404 SEK and a high forecast of 0.2916 SEK.

Lowest
Price Target
0.2404 SEK
453% Upside
Average
Price Target
0.2631 SEK
505% Upside
Highest
Price Target
0.2916 SEK
570% Upside
Active Biotech AB publ Competitors:
Price Targets
CSL
CSL Ltd
38% Upside
688331
RemeGen Co Ltd
12% Downside
EDIT
Editas Medicine Inc
148% Upside
ARX
Aroa Biosurgery Ltd
16% Upside
TLX
Telix Pharmaceuticals Ltd
128% Upside
ARQT
Arcutis Biotherapeutics Inc
25% Upside
ORKA
Oruka Therapeutics Inc
69% Upside
600201
Jinyu Bio-Technology Co Ltd
25% Downside

Revenue
Forecast

Revenue Estimate
Active Biotech AB publ

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Active Biotech AB publ

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Active Biotech AB publ

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACTI's stock price target?
Price Target
0.2631 SEK

According to Wall Street analysts, the average 1-year price target for ACTI is 0.2631 SEK with a low forecast of 0.2404 SEK and a high forecast of 0.2916 SEK.

Back to Top